Skip to main content

Want a detailed portfolio tracker?

ArriVent BioPharma (AVBP) P/E (2024 - 2026)

ArriVent BioPharma (AVBP) P/E from Jan 26, 2024 to Jul 21, 2026. The TTM ArriVent BioPharma (AVBP) P/E is -8.10. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ArriVent BioPharma (AVBP)

YearP/EChange
2026-8.10+78.14%
2025-4.55-59.10%
2024-11.12N/A

Comparison ArriVent BioPharma (AVBP) P/E with competitors

ArriVent BioPharma (AVBP) P/E is -8.10.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.92%
FGENFibroGen Inc0.24-102.96%
CHRSCoherus Biosciences Inc0.85-110.47%
FBIOFortress Biotech Inc0.95-111.71%
ORMPOramed Pharmaceuticals Inc1.50-118.55%
AGENAgenus Inc3.01-137.14%
INVAInnoviva Inc3.15-138.92%
VXRTVaxart Inc3.55-143.80%
CRMDCorMedix Inc3.63-144.77%
CVACCureVac N.V.4.45-154.85%
GLPGGalapagos NV4.86-159.95%
SRPTSarepta Therapeutics Inc4.88-160.24%
ABEOAbeona Therapeutics Inc5.39-166.48%
ABUSArbutus Biopharma Corp5.60-169.04%
ZVRAZevra Therapeutics Inc5.89-172.64%
SPROSpero Therapeutics Inc6.23-176.85%
CGENCompugen Ltd6.31-177.91%
RIGLRigel Pharmaceuticals6.87-184.79%
SLXNSilexion Therapeutics Corp7.30-190.02%
OMEROmeros Corporation9.26-214.24%
PLXProtalix BioTherapeutics Inc10.89-234.38%
ACADAcadia Pharmaceuticals Inc11.73-244.72%
TBPHTheravance Biopharma Inc12.26-251.30%
ADMAAdma Biologics Inc12.42-253.23%
HRMYHarmony Biosciences Holdings Inc13.82-270.53%
SABSSAB Biotherapeutics Inc14.14-274.42%
NAGENiagen Bioscience Inc14.82-282.84%
INCYIncyte Corp15.82-295.23%
REGNRegeneron Pharmaceuticals Inc15.86-295.65%
PBYIPuma Biotechnology Inc17.32-313.66%
CPRXCatalyst Pharmaceuticals Inc17.44-315.18%
EXELExelixis Inc17.54-316.40%
TGTXTG Therapeutics Inc18.97-334.02%
MDXGMimedx Group Inc20.55-353.59%
XOMAXOMA Royalty Corp22.87-382.25%
ARGXArgen X SE24.30-399.82%
CTMXCytomX Therapeutics Inc24.82-406.27%
XOMAOXOMA Royalty Corp25.34-412.73%
HALOHalozyme Therapeutics Inc25.62-416.18%
XOMAPXOMA Royalty Corp25.67-416.75%
VRTXVertex Pharmaceuticals Inc27.99-445.43%
RPRXRoyalty Pharma plc - Class A28.69-453.98%
SLNOSoleno Therapeutics Inc29.02-458.03%
ASNDAscendis Pharma A/S30.09-471.23%
LGNDLigand Pharmaceuticals Inc - Class B37.91-567.80%
APLSApellis Pharmaceuticals Inc39.02-581.49%
BMRNBiomarin Pharmaceutical Inc42.21-620.86%
KRYSKrystal Biotech Inc45.34-659.50%
ONCBeiGene Ltd69.54-958.07%
PHARPharming Group N.V.75.03-1025.75%
TECHBio-Techne Corp101.96-1358.08%
VCELVericel Corp109.92-1456.34%
ALNYAlnylam Pharmaceuticals Inc117.96-1555.59%
GMABGenmab140.29-1831.07%
TLXTelix Pharmaceuticals Ltd162.15-2100.83%
CORTCorcept Therapeutics Inc212.86-2726.49%